CD274 and non-small cell lung carcinoma: Furthermore, it was found that sequential administration of pemetrexed and cisplatin activated the STING pathway and ICD, and enhanced immune function through elevated levels of CD8+ infiltrating cells, as well as PD‐L1 upregulation in comparison to combination therapy in a NSCLC mouse model [125].